# Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery

> **NCT02919345** · PHASE4 · COMPLETED · sponsor: **University of Campinas, Brazil** · enrollment: 98 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Coronary Artery Disease
- Carotid Artery Diseases

## Interventions

- **DRUG:** Dapagliflozin 10 mg
- **DRUG:** Glibenclamide 5 mg

## Key facts

- **NCT ID:** NCT02919345
- **Lead sponsor:** University of Campinas, Brazil
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2018-12
- **Final completion:** 2019-03
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2023-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02919345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02919345, "Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02919345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*